Abbott India changed secretary: what it means for Abbott India stock

Published on 10/14/2026 at 00:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ICICI Securities set an INR 32,210 target on August 13, 2026. Abbott India stock posted INR 4.29 billion profit, up 17.10 percent.

Management change and earnings growth

Abbott India disclosed a company secretary resignation on September 7, 2026, effective October 28, 2026.
ICICI Securities set an INR 32,210.00 target on August 13, 2026.
Q1 FY27 profit reached INR 4.29 billion, up 17.10 percent year over year.
Abbott India approved an INR 656.00 per-share dividend for fiscal year 2026 on May 11, 2026.

Abbott India, INE358A01014, Illustration mit AI erstellt.

Abbott India changed its company secretary and compliance officer arrangement on September 7, 2026, with Sangeeta Shetty's resignation taking effect on October 28, according to AlfaFinder. For Abbott India stock, the personnel change comes alongside a stronger Q1 FY27 profit trend and a dated analyst target.

Three events shape the stock

On May 11, 2026, Abbott India approved a fiscal year 2026 total dividend of INR 656.00 per share, according to AlfaFinder. The same source reported Q4 FY26 revenue of INR 17.10 billion and net profit of INR 3.95 billion, with profit up 7.60 percent year over year.

On August 12, 2026, Abbott India reported Q1 FY27 revenue of INR 18.14 billion, up 4.30 percent year over year, and net profit of INR 4.29 billion, up 17.10 percent, according to AlfaFinder. The earnings mix matters: profit growth was nearly four times the pace of revenue growth.

What does the target imply?

On August 13, 2026, ICICI Securities retained a Buy recommendation and set a target of INR 32,210.00, compared with the report's reference price of INR 27,650.00, according to DSIJ. The target was based on 36.00 times projected fiscal year 2028 earnings per share, while the report identified slower Novo Nordisk brand sales and generic competition as risks.

Listing details and next date

Abbott India's next dated personnel milestone is October 28, 2026, when the resignation becomes effective, according to AlfaFinder. The company trades on the NSE under ticker ABBOTINDIA and is included in the Nifty Pharma index, according to AskNivesh.

Dividend frames shareholder return

The INR 656.00 per-share fiscal year 2026 dividend and the Q1 FY27 profit increase give investors two concrete reference points for evaluating Abbott India's premium pharmaceutical profile. The September 7 management change adds an operational milestone to that earnings picture.